Nov 10 2017
Glyphosate Not Associated with Cancer
In March of 2015 the International Agency for Research on Cancer (IARC), part of the World Health Organization (WHO), published their assessment on glyphosate, Monsanto’s popular weedkiller, classifying it as 2a – a probable carcinogen. This was like red meat to the anti-GMO crowd, and even sparked class action suits against Monsanto and may lead to banning use of the chemical in the EU.
There were significant problems with the IARC report, however. First – it is at odds with every other expert review of the scientific literature on glyphosate. I review the evidence here, citing many expert panel reviews, all conclude that the evidence does not support a link between glyphosate and risk of cancer. The IARC conclusion is a clear outlier, which reasonably prompts questions as to why their designation stands out.
We also need to put the IARC classification of 2a – probable carcinogen, into context. This is the same classification that the IARC gave to drinking hot beverages or eating red meat. Overall they tend to err on the side of caution when making their classification.
But there were problems that go beyond where the IARC sets their threshold for “probable.” Two main criticisms have emerged. The first is the lack of transparency. Reuters has published a series of articles on the issue, outlining, for example, that when the EPA reviewed the safety of glyphosate they also published a 1300 + page document that outlines the entire deliberative process. The IARC produced no such document.